Longevity AI

Overview
News
Longevity Tech?
Product stageSegments
Early
?
Diagnostics and lifestyle
?

Longevity AI has developed an operating system for proactive care that predicts and potentially prevents chronic disease. With AI, a professional dashboard, and a user app, its technology reportedly gives doctors and individual users the ability to obtain and act upon specific, personalized lifestyle interventions.


The company has developed systems for hospitals, health funds, and other medical organizations that allow them to track and monitor the health of their patients in real time.


Its platform makes risk predictions based on the latest scientific discoveries, evidence-based medicine, and personalized health information, allowing early diagnosis and intervention of major age-related diseases. The dashboard is claimed to provide insights and support doctors to understand the lifestyle changes that can have a positive impact on their patients. Medical professionals can send patients a holistic health report after every visit and gain insights into patient habits and preferences through integration with the Longevity AI app. The dashboard also enables doctors to monitor changes over time and better understand the biomarker evolution of their patients.


Its longevity lifestyle app is claimed to provide real-time suggestions for the next best action tailored to the unique needs and preferences of customers and help them stay on track and make progress toward a healthier life. This encompasses a personalized scoring system that offers a quick overview of the user’s current health state.

Key customers and partnerships


In April 2023. Longevity AI partnered with KSM, the research and innovation arm of Maccabi Healthcare Services, Israel’s leading health maintenance organization, to “model the aging process and slow it down with tailored medical AI.” The partners intend to conduct joint research designed to help medical professionals proactively prevent chronic diseases. The research would use anonymized Big Data resources and initially focus on cardiovascular disease.



HQ location:
Tel Aviv-yafo ISR
Founded year:
2021
Employees:
11-50
IPO status:
Private
Total funding:
-
Last Funding:
-
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.